IQVIA UK and Ireland ’s cover photo
IQVIA UK and Ireland

IQVIA UK and Ireland

Hospitals and Health Care

Together with the life sciences, National Health Service (NHS) and Health Service Executive (HSE).

About us

Together with the life sciences, National Health Service (NHS) and Health Service Executive (HSE) stakeholders we serve, we are enabling a more modern, effective, and efficient healthcare system, and creating breakthrough solutions that help transform business and patient outcomes. We believe that unparalleled data, advanced analytics and expertise and innovative technology can enable better decision-making for improving health outcomes and patient pathways: - Transform the clinical research ecosystem - Accelerate the discovery of new medicines - Inform clinical decision-making - Improve patient care pathways with quicker diagnoses and referrals - Accelerate patient access to innovative and personalized medicines

Industry
Hospitals and Health Care
Company size
10,001+ employees
Headquarters
London

Updates

  • We're excited to announce the release of our latest whitepaper, sharing details of our innovative collaboration with Reset Health and Roczen, and launching our Community Obesity Management Service. Key Highlights include: • Challenges of Obesity: Addressing the growing problem and its impact on the UK’s health and economy. • NICE Recommendations: Insights into the latest pharmacological treatments and their rollout. • Community Obesity Management Service (COMS): A data-driven, sustainable solution to support patients and clinicians. • Digital Health Services: Leveraging technology to provide wraparound support and real-world evidence. Read more about how our end-to-end Community Obesity Management Service can transform weight management services, making them more cost-effective and accessible: https://bit.ly/4j9Vsmw #WeightManagement #Obesity #DigitalHealth #DrivingHealthcareForward

    • No alternative text description for this image
  • Exciting news! 📢 We will be exhibiting at the HFMA Costing Conference next week! 🎉 Come visit our team at Stand 5 to explore how our cutting-edge costing solutions can empower NHS organisations to drive healthcare forward. 🚀 We're also thrilled to announce that IQVIA has renewed its corporate partnership with HFMA. As one of HFMA's longstanding partners, we’re proud to continue supporting NHS organisations in harnessing the power of data, analytics, and technology to transform healthcare. See you there! 👋 https://bit.ly/3R1vzth

    • No alternative text description for this image
  • Join us as we explore the shift towards more community-oriented care, specialised commissioning and the importance of seamless communication between different healthcare sectors. Stay tuned for a discussion on the growing collaboration and leadership within integrated care systems, empowering a more integrated approach to healthcare.

  • Thrilled to share that IQVIA has been recognised on Fortune® World's Most Admired Companies™ list, maintaining its leadership in 'Healthcare: Pharmacy and Other Services' for an impressive four consecutive years! Join us in our journey to transform healthcare globally!

    View organization page for IQVIA

    2,245,743 followers

    Proud Moment! IQVIA has been named to the Fortune® World's Most Admired Companies™ list, securing the top spot in 'Healthcare: Pharmacy and Other Services' for the last four years. Be a part of our mission to improve healthcare across the world: https://bit.ly/4iSUDyy #WeAreIQVIA #MostAdmiredCos

    • No alternative text description for this image
  • 📊 Dive into our latest factsheet on Regional Sales Analyser and Regional Sales Analyser DAC! This comprehensive data tool is designed to provide in-depth insights into regional sales data for Prescription and OTC products, helping you make informed business decisions and drive growth. Find out more about their features and how they can benefit your business in the link below: https://bit.ly/4l8Om3w

    • No alternative text description for this image
  • Explore the rise of e-commerce in the health and wellbeing market. Our white paper provides insights into the rapid growth of e-pharmacies and direct-to-consumer sales, with the market in the UK growing by 7% in 2024. Download your copy to review the e-commerce market trends in the UK. How can your organisation benefit from these trends? https://bit.ly/4hVPJ2W

    • No alternative text description for this image
  • Intriguing insights ahead on Making Market Access Real as we explore the dynamic changes expected in the healthcare environment. Join us as we delve into the core drivers of change, including integration and governance. Stay tuned for a deep dive into the shift towards joined-up services, interoperability of systems, and the impact on patient care. Don't miss out on this crucial conversation shaping the healthcare landscape.

  • CAR T-cell therapies could transform cancer treatment, but accessibility remains a challenge. Our new report highlights barriers like limited infrastructure, varied policies, and capacity constraints, while exploring opportunities to expand reach. Read more in our report here 👇

    CAR T-cell therapies have the potential to transform cancer treatment, but access remains a challenge. Our new independent report assesses health system readiness across seven countries, revealing key barriers and opportunities to optimize delivery. 🔵 Infrastructure and capacity constraints limit overall patient access 🔵 Referral networks and funding policies vary, affecting equitable treatment 🔵 Emerging best practices can improve efficiency and expand reach As CAR T-cell therapies advance, addressing these challenges is crucial to ensuring eligible patients can benefit from these innovative treatments. Full report: https://bit.ly/4ih3GcH. Funded and reviewed by Gilead and Kite. #Oncology #CancerCare #CancerTreatment #CellTherapy

    • No alternative text description for this image

Affiliated pages

Similar pages